Literature DB >> 12230280

Prostate cancer and coexisting incidental Paget's disease--report on a case.

A B Porcaro1, L Comunale, G Pistolesi, G Mobilio.   

Abstract

Prostate cancer coexisting with asymptomatic Paget's disease (osteitis deformans) may be difficult to stage. The skeletal lesions of both prostate cancer and Paget's disease may closely resemble each other, as appearing on imaging. A case of clinically localized prostate cancer coexisting with incidental Paget's disease is herein reported. Prostate cancer and coexisting incidental Paget's disease both need careful evaluation and close follow-up of the skeleton by imaging, because there is a risk of the former involving the skeleton at low clinical stages and low PSA serum levels, as well as the latter developing osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12230280     DOI: 10.1023/a:1019502903833

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  5 in total

1.  Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.

Authors:  F J Papatheofanis
Journal:  J Nucl Med       Date:  1997-08       Impact factor: 10.057

2.  [Paget's disease of bone: MR characteristics at 1.5 T].

Authors:  J Neuerburg; K Bohndorf; R Krasny
Journal:  Rofo       Date:  1988-12

3.  T1-weighted MR imaging for distinguishing large osteolysis of Paget's disease from sarcomatous degeneration.

Authors:  M Sundaram; G Khanna; G Y El-Khoury
Journal:  Skeletal Radiol       Date:  2001-07       Impact factor: 2.199

4.  Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.

Authors:  L F Wymenga; J H Boomsma; K Groenier; D A Piers; H J Mensink
Journal:  BJU Int       Date:  2001-08       Impact factor: 5.588

5.  Appendicular metastatic prostate cancer simulating osteosarcoma, Paget's disease, and Paget's sarcoma.

Authors:  D Igou; M Sundaram; D J McDonald; C Janney; D E Chalk
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.